Compass Therapeutics (CMPX) P/E (2021 - 2026)
Compass Therapeutics (CMPX) P/E from Apr 5, 2021 to Jul 20, 2026. The TTM Compass Therapeutics (CMPX) P/E is -4.88. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Compass Therapeutics (CMPX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -4.88 | -60.70% |
| 2025 | -12.42 | +207.17% |
| 2024 | -4.04 | -16.95% |
| 2023 | -4.87 | -61.08% |
| 2022 | -12.50 | +402.90% |
| 2021 | -2.49 | N/A |
Comparison Compass Therapeutics (CMPX) P/E with competitors
Compass Therapeutics (CMPX) P/E is -4.88.